Clinical trial
Prospective Observational Study of Long-term Pathogenic Treatment of Elizaria® in Patients With Atypical Hemolytic Uremic Syndrome
NCT04749810 is registered in ClinicalTrials.gov with AO GENERIUM as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Observational Study of Long-term Pathogenic Treatment of Elizaria® in Patients With Atypical Hemolytic Uremic Syndrome
- Lead sponsor
- AO GENERIUM
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 19, 2019
- Completion date
- April 30, 2022
- Enrollment
- 50 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.